{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:55Z","timestamp":1788754135626,"version":"build-2803163510"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40121-025-01166-7","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:37:54Z","timestamp":1748968674000},"page":"1381-1403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination"],"prefix":"10.1007","volume":"14","author":[{"given":"Jessica","family":"Presa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.","family":"Fergie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hanenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Zimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Peyrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"1166_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3201\/eid1904.111799","volume":"19","author":"OB Harrison","year":"2013","unstructured":"Harrison OB, Claus H, Jiang Y, et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis. 2013;19:566\u201373.","journal-title":"Emerg Infect Dis"},{"key":"1166_CR2","doi-asserted-by":"crossref","unstructured":"Pardo de Santayana C, Tin Tin Htar M, Findlow J, Balmer P. Epidemiology of invasive meningococcal disease worldwide from 2010\u20132019: a literature review. Epidemiol Infect. 2023;151:e57.","DOI":"10.1017\/S0950268823000328"},{"key":"1166_CR3","unstructured":"Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Report, 2018. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/111348. Accessed September 23, 2022."},{"key":"1166_CR4","unstructured":"Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Report, 2017. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/75419. Accessed March 03, 2025."},{"key":"1166_CR5","unstructured":"Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Report, 2019. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/140466. Accessed March 03, 2025."},{"key":"1166_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jamapediatrics.2020.1990","volume":"174","author":"S Mbaeyi","year":"2020","unstructured":"Mbaeyi S, Pondo T, Blain A, et al. Incidence of meningococcal disease before and after implementation of quadrivalent meningococcal conjugate vaccine in the United States. JAMA Pediatr. 2020;174:843\u201351.","journal-title":"JAMA Pediatr"},{"key":"1166_CR7","unstructured":"Centers for Disease Control and Prevention. Meningococcal Disease Surveillance and Trends (last updated November 12, 2024). Available at: https:\/\/www.cdc.gov\/meningococcal\/php\/surveillance\/index.html. Accessed February 17, 2025."},{"key":"1166_CR8","unstructured":"Centers for Disease Control and Prevention. CDC Stacks. National Notifiable Diseases: Infectious Weekly Tables. Meningococcal Disease. Week ending December 30, 2023. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/140265. Accessed April 09, 2025."},{"key":"1166_CR9","unstructured":"Centers for Disease Control and Prevention. CDC Stacks. National Notifiable Diseases: Infectious Weekly Tables. Meningococcal Disease. Week ending December 31, 2022. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/123383. Accessed April 09, 2025."},{"key":"1166_CR10","unstructured":"Centers for Disease Control and Prevention. Enhanced Meningococcal Disease Surveillance Report, 2020. Available at: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2020.pdf. Accessed April 09, 2025."},{"key":"1166_CR11","unstructured":"Centers for Disease Control and Prevention. CDC Stacks. National Notifiable Diseases: Infectious Weekly Tables. Meningococcal Disease. Week ending December 28, 2024. Available at: https:\/\/stacks.cdc.gov\/view\/cdc\/175359. Accessed March 26, 2025."},{"key":"1166_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jpids\/piz024","volume":"9","author":"GS Marshall","year":"2020","unstructured":"Marshall GS, Dempsey AF, Srivastava A, Isturiz RE. US college students are at increased risk for serogroup B meningococcal disease. J Pediatric Infect Dis Soc. 2020;9:244\u20137.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"1166_CR13","unstructured":"Centers for Disease Control and Prevention. CDC Archive. Meningococcal Disease Outbreak Among Gay, Bisexual Men in Florida, 2021\u201323. Available at: https:\/\/archive.cdc.gov\/#\/details?q=https:\/\/www.cdc.gov\/meningococcal\/outbreaks\/FL2022.html&start=0&rows=10&url=https:\/\/www.cdc.gov\/meningococcal\/outbreaks\/FL2022.html. Accessed April 09, 2025."},{"key":"1166_CR14","unstructured":"Centers for Disease Control and Prevention. CDC Archive. CDC Assists with Meningococcal Disease Outbreak Investigation in Florida. Available at: https:\/\/archive.cdc.gov\/#\/details?archive_url=https:\/\/archive.cdc.gov\/www_cdc_gov\/media\/releases\/2022\/p0622-Meningococcal-Outbreak.html. Accessed April 09, 2025."},{"key":"1166_CR15","unstructured":"Virginia Department of Health. Meningococcal Disease Outbreak Response. Available at: https:\/\/www.vdh.virginia.gov\/surveillance-and-investigation\/meningococcal-disease-outbreak-response\/. Accessed April 03, 2025."},{"key":"1166_CR16","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s40121-021-00499-3","volume":"10","author":"L Soumahoro","year":"2021","unstructured":"Soumahoro L, Abitbol V, Vicic N, Bekkat-Berkani R, Safadi MAP. Meningococcal disease outbreaks: a moving target and a case for routine preventative vaccination. Infect Dis Ther. 2021;10:1949\u201388.","journal-title":"Infect Dis Ther"},{"key":"1166_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23744235.2021.1971289","volume":"54","author":"A-E Deghmane","year":"2022","unstructured":"Deghmane A-E, Taha S, Taha M-K. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis. 2022;54:1\u20137.","journal-title":"Infect Dis"},{"key":"1166_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fped.2018.00321","volume":"6","author":"S Nadel","year":"2018","unstructured":"Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Front Pediatr. 2018;6:321.","journal-title":"Front Pediatr"},{"key":"1166_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","volume":"367","author":"MJ Thompson","year":"2006","unstructured":"Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367:397\u2013403.","journal-title":"Lancet"},{"key":"1166_CR20","doi-asserted-by":"crossref","unstructured":"Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37:2768\u201382.","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"1166_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12889-022-12933-3","volume":"22","author":"S Guedes","year":"2022","unstructured":"Guedes S, Bricout H, Langevin E, Tong S, Bertrand-Gerentes I. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis. BMC Public Health. 2022;22:521.","journal-title":"BMC Public Health"},{"key":"1166_CR22","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/INF.0b013e3182706b89","volume":"31","author":"JA Bettinger","year":"2013","unstructured":"Bettinger JA, Scheifele DW, Le Saux N, et al. The disease burden of invasive meningococcal serogroup B disease in Canada. Pediatr Infect Dis J. 2013;31:e20\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"1166_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","volume":"7","author":"KJ Olbrich","year":"2018","unstructured":"Olbrich KJ, Muller D, Schumacher S, et al. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7:421\u201338.","journal-title":"Infect Dis Ther"},{"key":"1166_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/jnnp.2006.110023","volume":"78","author":"M Hoogman","year":"2007","unstructured":"Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry. 2007;78:1092\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1166_CR25","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1542\/peds.2008-0581","volume":"123","author":"J Borg","year":"2009","unstructured":"Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123:e502\u20139.","journal-title":"Pediatrics"},{"key":"1166_CR26","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","volume":"59","author":"F Martin\u00f3n-Torres","year":"2016","unstructured":"Martin\u00f3n-Torres F. Deciphering the burden of meningococcal disease: conventional and under-recognized elements. J Adolesc Health. 2016;59:S12-20.","journal-title":"J Adolesc Health"},{"key":"1166_CR27","doi-asserted-by":"crossref","unstructured":"Candrilli SD, Kurosky S. The response to and cost of meningococcal disease outbreaks in university campus settings: a case study in Oregon, United States. Research Triangle Park (NC): 2019.","DOI":"10.3768\/rtipress.2019.rr.0034.1910"},{"key":"1166_CR28","unstructured":"Centers for Disease Control and Prevention. Meningococcal Vaccination (updated June 26, 2024). Available at: https:\/\/www.cdc.gov\/meningococcal\/vaccines\/index.html. Accessed February 11, 2025."},{"key":"1166_CR29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jadohealth.2024.01.016","volume":"74","author":"J Presa","year":"2024","unstructured":"Presa J, Findlow J, Zimet GD. Meningococcal vaccination of adolescents in the United States: past successes and future considerations. J Adolesc Health. 2024;74:1068\u201377.","journal-title":"J Adolesc Health"},{"key":"1166_CR30","unstructured":"California Department of Public Health. Replacement of Menactra with Menquadfi Meningococcal Conjugate Vaccine on the ADAP & PrEP-AP Formulary. Available at: https:\/\/www.cdph.ca.gov\/Programs\/CID\/DOA\/Pages\/OA_ADAP_MM_2022_20_Replacement_of_Menactra_with_Menquadfi_Meningococcal_Conjugate_Vaccine.aspx#:~:text=Effective%20September%2026%2C%202022%2C%20Menactra,Meningococcal%20Conjugate%20Vaccine%20in%202022. Accessed April 2, 2024."},{"key":"1166_CR31","doi-asserted-by":"publisher","first-page":"7014","DOI":"10.1016\/j.vaccine.2022.09.077","volume":"40","author":"L Serra","year":"2022","unstructured":"Serra L, Webber C, Burman C, et al. Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine. Vaccine. 2022;40:7014\u201321.","journal-title":"Vaccine"},{"key":"1166_CR32","unstructured":"Penbraya (meningococcal groups A, B, C, W, and Y vaccine). Full Prescribing Information, Pfizer Ireland Pharmaceuticals, Cork, Ireland, 2023."},{"key":"1166_CR33","unstructured":"Pfizer Inc. FDA Approves Penbraya\u2122, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents. Available at: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/fda-approves-penbrayatm-first-and-only-vaccine-prevention. Accessed April 28, 2025."},{"key":"1166_CR34","unstructured":"US Food and Drug Administration. PENMENVY Package Insert, Updated 02\/2024. Available at: https:\/\/www.fda.gov\/vaccines-blood-biologics\/penmenvy. Accessed April 01, 2025."},{"key":"1166_CR35","unstructured":"GSK. Press release February 15, 2025. Penmenvy, GSK\u2019s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY. Available at: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/penmenvy-gsk-s-5-in-1-meningococcal-vaccine-approved-by-us-fda-to-help-protect-against-menabcwy\/. Accessed April 29, 2025."},{"key":"1166_CR36","first-page":"1","volume":"54","author":"OO Bilukha","year":"2005","unstructured":"Bilukha OO, Rosenstein N. National Center for Infectious Diseases\/Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54:1\u201321.","journal-title":"MMWR Recomm Rep."},{"key":"1166_CR37","unstructured":"Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2011;60:72\u20136."},{"key":"1166_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","volume":"64","author":"JR MacNeil","year":"2015","unstructured":"MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1171\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1166_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","volume":"69","author":"SA Mbaeyi","year":"2020","unstructured":"Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69:1\u201341.","journal-title":"MMWR Recomm Rep"},{"key":"1166_CR40","unstructured":"Centers for Disease Control and Prevention. Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger. Available at: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf. Accessed September 13, 2024."},{"key":"1166_CR41","unstructured":"Centers for Disease Control and Prevention. ACIP Recommendations. Available at: https:\/\/www.cdc.gov\/acip\/vaccine-recommendations\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html. Accessed October 17, 2024."},{"key":"1166_CR42","unstructured":"Advisory Committee on Immunization Practices. April 15\u201316, 2025 Meeting. GSK Pentavalent (MenABCWY) Vaccine: Review of Updated EtR and Work Group Considerations. Available at: https:\/\/www.cdc.gov\/acip\/meetings\/presentation-slides-april-15-16-2025.html. Accessed April 29, 2025."},{"key":"1166_CR43","unstructured":"University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP). CDC Advisers Update Recommendations for Meningococcal, RSV, Chikungunya Vaccines. Available at: https:\/\/www.cidrap.umn.edu\/chikungunya\/cdc-advisers-update-recommendations-meningococcal-rsv-chikungunya-vaccines. Accessed April 29, 2025."},{"key":"1166_CR44","doi-asserted-by":"publisher","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","volume":"72","author":"C Pingali","year":"2023","unstructured":"Pingali C, Yankey D, Elam-Evans LD, et al. Vaccination coverage among adolescents aged 13\u201317 years - National Immunization Survey-Teen, United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72:912\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1166_CR45","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-057855","volume":"150","author":"MD Shah","year":"2022","unstructured":"Shah MD, Szilagyi PG, Shetgiri R, et al. Trends in parents\u2019 confidence in childhood vaccines during the COVID-19 pandemic. Pediatrics. 2022;150: e2022057855.","journal-title":"Pediatrics"},{"key":"1166_CR46","unstructured":"Herrera-Restrepo O, Bunniran S, Mond T, et al. United States physicians\u2019 knowledge, attitudes, and practices regarding meningococcal vaccination for healthy adolescents and young adults. J Adolesc Health. 2024;13:S1054\u2013139X(23)00975\u20138."},{"key":"1166_CR47","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.acap.2018.04.005","volume":"18","author":"A Kempe","year":"2018","unstructured":"Kempe A, Allison MA, MacNeil JR, et al. Knowledge and attitudes regarding category B ACIP recommendations among primary care providers for children. Acad Pediatr. 2018;18:763\u20138.","journal-title":"Acad Pediatr"},{"key":"1166_CR48","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/21645515.2019.1682845","volume":"16","author":"L Huang","year":"2020","unstructured":"Huang L, Goren A, Lee LK, et al. Disparities in healthcare providers\u2019 interpretations and implementations of ACIP\u2019s meningococcal vaccine recommendations. Hum Vaccin Immunother. 2020;16:933\u201344.","journal-title":"Hum Vaccin Immunother"},{"key":"1166_CR49","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.8573","volume":"5","author":"PK Ghaswalla","year":"2022","unstructured":"Ghaswalla PK, Marshall GS, Bengtson LGS, et al. Meningococcal vaccination rates among people with a new diagnosis of HIV infection in the US. JAMA Netw Open. 2022;5: e228573.","journal-title":"JAMA Netw Open"},{"key":"1166_CR50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.vaccine.2020.11.068","volume":"39","author":"PK Ghaswalla","year":"2021","unstructured":"Ghaswalla PK, Bengtson LGS, Marshall GS, et al. Meningococcal vaccination in patients with newly diagnosed asplenia in the United States. Vaccine. 2021;39:272\u201381.","journal-title":"Vaccine"},{"key":"1166_CR51","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.vaccine.2018.11.078","volume":"37","author":"NE Basta","year":"2019","unstructured":"Basta NE, Becker AB, Li Q, Nederhoff D. Parental awareness of meningococcal B vaccines and willingness to vaccinate their teens. Vaccine. 2019;37:670\u20136.","journal-title":"Vaccine"},{"key":"1166_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/INF.0000000000003033","volume":"40","author":"J Fergie","year":"2021","unstructured":"Fergie J, Howard A, Huang L, Srivastava A. Implementation experience with meningococcal serogroup B vaccines in the United States: impact of a nonroutine recommendation. Pediatr Infect Dis J. 2021;40:269\u201375.","journal-title":"Pediatr Infect Dis J"},{"key":"1166_CR53","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1186\/s12889-020-09181-8","volume":"20","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Dempsey A, Galitsky A, Fahimi M, Huang L. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States. BMC Public Health. 2020;20:1109.","journal-title":"BMC Public Health"},{"key":"1166_CR54","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/07448481.2020.1772270","volume":"70","author":"AK Ulrich","year":"2022","unstructured":"Ulrich AK, McKearnan SB, Lammert S, et al. Validity of university students\u2019 self-reported vaccination status after a meningococcal B outbreak. J Am Coll Health. 2022;70:824\u20139.","journal-title":"J Am Coll Health"},{"key":"1166_CR55","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.vaccine.2017.02.011","volume":"35","author":"DM MacDougall","year":"2017","unstructured":"MacDougall DM, Langley JM, Li L, et al. Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program. Vaccine. 2017;35:2520\u201330.","journal-title":"Vaccine"},{"key":"1166_CR56","unstructured":"Centers for Disease Control and Prevention. ACIP Shared Clinical Decision-Making Recommendations (updated January 7, 2025). Available at: https:\/\/www.cdc.gov\/acip\/vaccine-recommendations\/shared-clinical-decision-making.html. Accessed February 14, 2025."},{"key":"1166_CR57","unstructured":"Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices Vaccines for Children Program: Vaccines to Prevent Meningococcal Disease. Available at: https:\/\/www.cdc.gov\/vaccines-for-children\/downloads\/meningococcal-508.pdf. Accessed 21 May 2025."},{"key":"1166_CR58","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0344","volume":"142","author":"A Kempe","year":"2018","unstructured":"Kempe A, Allison MA, MacNeil JR, et al. Adoption of serogroup B meningococcal vaccine recommendations. Pediatrics. 2018;142: e20180344.","journal-title":"Pediatrics"},{"key":"1166_CR59","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1080\/21645515.2020.1754052","volume":"16","author":"LM Niccolai","year":"2020","unstructured":"Niccolai LM, Hansen CE. Suboptimal uptake of meningococcal vaccines among older adolescents: barriers, solutions, and future research directions. Hum Vaccin Immunother. 2020;16:3208\u201312.","journal-title":"Hum Vaccin Immunother"},{"key":"1166_CR60","unstructured":"Immunization Action Coalition. MenACWY Vaccine Requirements for Secondary School. Available at: https:\/\/www.immunize.org\/official-guidance\/state-policies\/vaccine-requirements\/menacwy-secondary\/. Accessed April 4, 2024."},{"key":"1166_CR61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.acap.2022.01.006","volume":"22","author":"AB Middleman","year":"2022","unstructured":"Middleman AB, Zimet GD, Srivastava AK, Auslander BA. Making a shared decision on meningococcal B vaccine: provider feedback on an educational tool developed for use with patients. Acad Pediatr. 2022;22:564\u201372.","journal-title":"Acad Pediatr"},{"key":"1166_CR62","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3484","volume":"139","author":"GS Marshall","year":"2017","unstructured":"Marshall GS, Tan L. Understanding the category B recommendation for serogroup B meningococcal vaccine. Pediatrics. 2017;139: e20163484.","journal-title":"Pediatrics"},{"key":"1166_CR63","unstructured":"Centers for Disease Control and Prevention. TeenVaxView: Vaccination Coverage among Adolescents (13\u201317 Years). Available at: https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/teenvaxview\/data-reports\/index.html. Accessed April 5, 2024."},{"key":"1166_CR64","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/vaccines11020256","volume":"11","author":"C Masaquel","year":"2023","unstructured":"Masaquel C, Schley K, Wright K, et al. The impact of social determinants of health on meningococcal vaccination awareness, delivery, and coverage in adolescents and young adults in the United States: a systematic review. Vaccines (Basel). 2023;11:256.","journal-title":"Vaccines (Basel)"},{"key":"1166_CR65","unstructured":"Bright Futures\/American Academy of Pediatrics. Recommendations for Preventive Pediatric Health Care. Available at: https:\/\/downloads.aap.org\/AAP\/PDF\/periodicity_schedule.pdf. Accessed March 22, 2024."},{"key":"1166_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.amepre.2015.02.022","volume":"49","author":"SH Adams","year":"2015","unstructured":"Adams SH, Park MJ, Irwin CE Jr. Adolescent and young adult preventive care: comparing national survey rates. Am J Prev Med. 2015;49:238\u201347.","journal-title":"Am J Prev Med"},{"key":"1166_CR67","unstructured":"U.S. Department of Health and Human Services. Healthy People 2030. Available at: https:\/\/health.gov\/healthypeople\/objectives-and-data\/browse-objectives\/adolescents\/increase-proportion-adolescents-who-had-preventive-health-care-visit-past-year-ah-01\/data. Accessed May 22, 2024."},{"key":"1166_CR68","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.acap.2018.01.002","volume":"18","author":"CM Rand","year":"2018","unstructured":"Rand CM, Goldstein NPN. Patterns of primary care physician visits for US adolescents in 2014: implications for vaccination. Acad Pediatr. 2018;18:S72\u20138.","journal-title":"Acad Pediatr"},{"key":"1166_CR69","doi-asserted-by":"publisher","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","volume":"68","author":"E Meites","year":"2019","unstructured":"Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68:698\u2013702.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1166_CR70","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","volume":"72","author":"M Melgar","year":"2023","unstructured":"Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:793\u2013801.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1166_CR71","unstructured":"Centers for Disease Control and Prevention. CDC Updates RSV Vaccination Recommendation for Adults. June 26, 2024. Available at: https:\/\/www.cdc.gov\/media\/releases\/2024\/s-0626-vaccination-adults.html. Accessed April 04, 2025."},{"key":"1166_CR72","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archpedi.161.3.252","volume":"161","author":"CM Rand","year":"2007","unstructured":"Rand CM, Shone LP, Albertin C, et al. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161:252\u20139.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1166_CR73","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/MOP.0000000000000843","volume":"32","author":"JR Cataldi","year":"2020","unstructured":"Cataldi JR, Kerns ME, O\u2019Leary ST. Evidence-based strategies to increase vaccination uptake: a review. Curr Opin Pediatr. 2020;32:151\u20139.","journal-title":"Curr Opin Pediatr"},{"key":"1166_CR74","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/jpids\/pix067","volume":"6","author":"CM Espinosa","year":"2017","unstructured":"Espinosa CM, Marshall GS, Woods CR, et al. Missed opportunities for human papillomavirus vaccine initiation in an insured adolescent female population. J Pediatric Infect Dis Soc. 2017;6:360\u20135.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"256\u201362","key":"1166_CR75","volume":"195","author":"PJ Lu","year":"2018","unstructured":"Lu PJ, Yankey D, Jeyarajah J, et al. Association of health insurance status and vaccination coverage among adolescents 13\u201317 years of age. J Pediatr. 2018;195(256\u201362): e1.","journal-title":"J Pediatr"},{"key":"1166_CR76","unstructured":"Centers for Disease Control and Prevention (CDC). About the Vaccines for Children (VFC) Program. Available at: https:\/\/www.cdc.gov\/vaccines-for-children\/about\/index.html. Accessed 04 April, 2025."},{"key":"1166_CR77","unstructured":"Centers for Disease Control and Prevention (CDC). Vaccines for Children (VFC) Program: Information for Parents. Available at: https:\/\/www.cdc.gov\/vaccines-for-children\/vfc-information-for-parents\/index.html. Accessed April 04, 2025."},{"key":"1166_CR78","unstructured":"Centers for Disease Control and Prevention (CDC). Resources for Adult Vaccination Insurance and Payment. Available at: https:\/\/www.cdc.gov\/vaccines-adults\/hcp\/adult-payment-insurance-resources\/index.html#:~:text=Private%20Insurance%20Coverage,not%20met%20their%20yearly%20deductible. Accessed April 04, 2025."},{"key":"1166_CR79","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1080\/21645515.2019.1571891","volume":"15","author":"R Herman","year":"2019","unstructured":"Herman R, McNutt LA, Mehta M, et al. Vaccination perspectives among adolescents and their desired role in the decision-making process. Hum Vaccin Immunother. 2019;15:1752\u20139.","journal-title":"Hum Vaccin Immunother"},{"key":"1166_CR80","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-053458","author":"M Sharko","year":"2022","unstructured":"Sharko M, Jameson R, Ancker JS, et al. State-by-state variability in adolescent privacy laws. Pediatrics. 2022. https:\/\/doi.org\/10.1542\/peds.2021-053458.","journal-title":"Pediatrics."},{"key":"1166_CR81","unstructured":"American Medical Association. AMA Adopts New Policies on First Day of Voting at 2019 Annual Meeting. Available at: https:\/\/www.ama-assn.org\/press-center\/press-releases\/ama-adopts-new-policies-first-day-voting-2019-annual-meeting. Accessed April 4, 2024."},{"key":"1166_CR82","doi-asserted-by":"crossref","unstructured":"Society for Adolescent Health and Medicine, English A, Ford CA, et al. Adolescent consent for vaccination: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health. 2013;53:550\u20133.","DOI":"10.1016\/j.jadohealth.2013.07.039"},{"key":"1166_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-022-01794-2","author":"D Watson","year":"2023","unstructured":"Watson D, Mhlaba M, Molelekeng G, et al. How do we best engage young people in decision-making about their health? A scoping review of deliberative priority setting methods. Int J Equity Health. 2023. https:\/\/doi.org\/10.1186\/s12939-022-01794-2.","journal-title":"Int J Equity Health."},{"key":"1166_CR84","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3150","author":"EM Alderman","year":"2019","unstructured":"Alderman EM, Breuner CC, Committee on Adolescence. Unique needs of the adolescent. Pediatrics. 2019. https:\/\/doi.org\/10.1542\/peds.2019-3150.","journal-title":"Pediatrics."},{"key":"1166_CR85","unstructured":"Immunize.org. Exemptions Permitted for State Childcare and School (Kg\u2013Gr 12). Available at: https:\/\/www.immunize.org\/official-guidance\/state-policies\/vaccine-requirements\/exemptions-childcare-school\/. Accessed May 8, 2024."},{"key":"1166_CR86","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/21645515.2020.1712934","volume":"16","author":"T Srivastava","year":"2020","unstructured":"Srivastava T, Emmer K, Feemster KA. Impact of school-entry vaccination requirement changes on clinical practice implementation and adolescent vaccination rates in metropolitan Philadelphia. Hum Vaccin Immunother. 2020;16:1155\u201365.","journal-title":"Hum Vaccin Immunother"},{"key":"1166_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002994","volume":"16","author":"S Nyathi","year":"2019","unstructured":"Nyathi S, Karpel HC, Sainani KL, et al. The 2016 California policy to eliminate nonmedical vaccine exemptions and changes in vaccine coverage: an empirical policy analysis. PLoS Med. 2019;16: e1002994.","journal-title":"PLoS Med"},{"key":"1166_CR88","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.9778\/cmajo.20180191","volume":"7","author":"D Greyson","year":"2019","unstructured":"Greyson D, Vriesema-Magnuson C, Bettinger JA. Impact of school vaccination mandates on pediatric vaccination coverage: a systematic review. CMAJ Open. 2019;7:E524\u201336.","journal-title":"CMAJ Open"},{"key":"1166_CR89","unstructured":"Immunize.org. State Meningococcal ACWY (MenACWY) Vaccine Requirements for Colleges and Universities. Available at: https:\/\/www.immunize.org\/laws\/menin.asp. Accessed November 3, 2023."},{"key":"1166_CR90","unstructured":"National Student Clearinghouse Research Center. Term Enrollment Estimates Spring 2022. Available at: https:\/\/nscresearchcenter.org\/wp-content\/uploads\/CTEE_Report_Spring_2022.pdf. Accessed April 11, 2024."},{"key":"1166_CR91","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00431-019-03511-8","volume":"179","author":"C Azzari","year":"2020","unstructured":"Azzari C, Diez-Domingo J, Eisenstein E, et al. Experts\u2019 opinion for improving global adolescent vaccination rates: a call to action. Eur J Pediatr. 2020;179:547\u201353.","journal-title":"Eur J Pediatr"},{"key":"1166_CR92","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11606-010-1291-3","volume":"25","author":"KC Stange","year":"2010","unstructured":"Stange KC, Nutting PA, Miller WL, et al. Defining and measuring the patient-centered medical home. J Gen Intern Med. 2010;25:601\u201312.","journal-title":"J Gen Intern Med"},{"key":"1166_CR93","unstructured":"National Alliance of State Pharmacy Associations. Pharmacist Administered Vaccines. Available at: https:\/\/naspa.us\/wp-content\/uploads\/2021\/01\/Pharmacist-Immunization-Authority-April-2023.pdf. Accessed April 4, 2024."},{"key":"1166_CR94","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1158\/1055-9965.EPI-18-0380","volume":"27","author":"PD Shah","year":"2018","unstructured":"Shah PD, Calo WA, Marciniak MW, Gilkey MB, Brewer NT. Support for pharmacist-provided HPV vaccination: national surveys of U.S. physicians and parents. Cancer Epidemiol Biomarkers Prev. 2018;27:970\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"1166_CR95","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.japh.2022.10.008","volume":"63","author":"TJ Varisco","year":"2023","unstructured":"Varisco TJ, Downs CG, Sansgiry SS, et al. Parents\u2019 intention to have their child vaccinated at a community pharmacy: a national cross-sectional survey. J Am Pharm Assoc. 2023;63:511-7e8.","journal-title":"J Am Pharm Assoc"},{"key":"1166_CR96","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1016\/j.vaccine.2016.08.085","volume":"34","author":"JE Isenor","year":"2016","unstructured":"Isenor JE, Edwards NT, Alia TA, et al. Impact of pharmacists as immunizers on vaccination rates: a systematic review and meta-analysis. Vaccine. 2016;34:5708\u201323.","journal-title":"Vaccine"},{"key":"1166_CR97","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1080\/21645515.2016.1176651","volume":"13","author":"M Rothholz","year":"2017","unstructured":"Rothholz M, Tan LLJ. Promoting the immunization neighborhood: benefits and challenges of pharmacies as additional locations for HPV vaccination. Hum Vaccin Immunother. 2017;13:1856\u20138.","journal-title":"Hum Vaccin Immunother"},{"key":"1166_CR98","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s40121-022-00609-9","volume":"11","author":"GS Marshall","year":"2022","unstructured":"Marshall GS, Fergie J, Presa J, Peyrani P. Rationale for the development of a pentavalent meningococcal vaccine: a US-focused review. Infect Dis Ther. 2022;11:937\u201351.","journal-title":"Infect Dis Ther"},{"key":"1166_CR99","unstructured":"McNamara L. Plan for Revisiting the Adolescent Schedule for Meningococcal Vaccines. Available at: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-10-25-26\/02-Meningococcal-McNamara-508.pdf#:~:text=Plan%20for%20revisiting%20the%20adolescent%20schedule%20for%20meningococcal. Accessed September 17, 2024."},{"key":"1166_CR100","unstructured":"Collins J. Advisory Committee on Immunization Practices (ACIP) Meeting. October 25, 2023. Summary of EtR and proposed recommendations for Pfizer\u2019s MenABCWY vaccine. Available at: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-10-25-26\/04-Meningococcal-Collins-508.pdf. Accessed 21 May 2025."},{"key":"1166_CR101","unstructured":"Kroger A, Bahta L, Long S, Sanchez P. General Best Practice Guidelines for Immunization. 2023. Available at: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/downloads\/general-recs.pdf. Accesssed 20 May 2025."},{"key":"1166_CR102","first-page":"608","volume":"64","author":"T Folaranmi","year":"2015","unstructured":"Folaranmi T, Rubin L, Martin SW, et al. Use of serogroup B meningococcal vaccines in persons aged \u226510 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:608\u201312.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1166_CR103","unstructured":"Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep. 2009;58:1042\u20133."},{"key":"1166_CR104","unstructured":"Menveo (meningococcal [groups A, C, Y, and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine). Full Prescribing Information, GlaxoSmithKline, Durham, NC, 2022."},{"key":"1166_CR105","unstructured":"MenQuadfi (meningococcal [groups A, C, Y, W] conjugate vaccine). Full Prescribing Information, Sanofi Pasteur Inc., Swiftwater, PA, 2022."},{"key":"1166_CR106","unstructured":"Trumenba (meningococcal group B vaccine). Full Prescribing Information, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, Philadelphia, PA, 2024."},{"key":"1166_CR107","unstructured":"Bexsero (meningococcal group B vaccine). Full Prescribing Information, GlaxoSmithKline, Research Triangle Park, NC, 2022."},{"key":"1166_CR108","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/14760584.2022.2064850","volume":"21","author":"J Findlow","year":"2022","unstructured":"Findlow J, Borrow R, Stephens DS, et al. Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage. Expert Rev Vaccines. 2022;21:753\u201369.","journal-title":"Expert Rev Vaccines"},{"key":"1166_CR109","unstructured":"US Food & Drug Administration. Summary Basis for Regulatory Action. PENBRAYA. November 17, 2023. Available at: https:\/\/www.fda.gov\/media\/174155\/download. Accessed April 02, 2025."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01166-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01166-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01166-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:28:09Z","timestamp":1757179689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01166-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":109,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01166-7","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following authors received honoraria from Pfizer Inc to attend the 2022 ARTEMIS meeting: Ruth Carrico, Jaime E. Fergie, Stephanie Hanenberg, Gary S. Marshall, Kaitlyn Rivard, Jana Shaw, and Gregory D. Zimet. Ruth Carrico is a consultant and advisory board member for Pfizer, Moderna, Sanofi, and Novavax, and a speaker for Pfizer. Jaime E. Fergie is a consultant and speaker for Pfizer, Sanofi, and GSK and a consultant for Moderna, Novavax, and Merck. Gary S. Marshall has received grants and\/or contracts (paid to the institution) from GSK, Merck, Pfizer, Sanofi, and Seqirus. He further discloses advisory board participation, consulting fees, and travel\/meeting support from GSK, Merck, Moderna, Pfizer, Sanofi, and Seqirus. Kaitlyn Rivard serves as an advisory board member for Pfizer and is a paid consultant for Wolters Kluwer. Jana Shaw is a consultant and speaker for Pfizer Inc, and a consultant for GSK. Gregory D. Zimet has served as an external advisory board member for Merck, Pfizer, and Moderna and as a consultant to Merck; has received investigator-initiated research funding from Merck administered through Indiana University; and serves as an unpaid member of the Board of Directors for the Unity Consortium, a nonprofit organization that supports adolescent health through vaccination. Jessica Presa, Paula Peyrani, and Alejandro Cane are current employees of Pfizer and may have stock or stock options.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}